[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

China Research and Intelligence Co., Ltd.: Market Research Reports

China Research and Intelligence (CRI) has emerged to provide high-level research and advisory services to all those with keen interest in different Chinese markets and industries. The firm, founded in 2007, is headquartered in Shanghai, China. Their team’s principle goal is to present the most helpful and reliable insights and information, sincerely serving a broad choice of multinational and local customers with their business practice and ethics.

CRI’s reports are packed with precise analysis of key market indicators, strategic recommendations from industry experts, market estimated figures, projections, reviews of competitive strategies, consumers investigation, reviews of business models, market share analyses, key forces driving of restraining market growth.

CRI’s scope of offerings encircles numerous market research reports, industry analytical reviews, company business reports, industry-specific research databases. Further, the company also offers outsource and custom-tailored services for research organisations, and multiple report readers.

Publications found: 1,023
Sort by:
Research Report on China's Alectinib Market, 2021-2025 US$ 2,600.00

Lung cancer is the most common type of cancer and the leading cause of cancer deaths. 4.57 million new cancer cases were reported in China in 2020, including 820,000 lung cancer cases. 3 million cance...

September 2021 40 pages
Research Report on China's Anastrozole Market, 2021-2025 US$ 2,600.00

According to IARC’s 2020 World Cancer Report, the number of new cases of breast cancer reached 2.26 million in 2020, larger than that of lung cancer cases which was 2.2 million. Breast cancer has beco...

September 2021 40 pages
Research Report on China's Dabigatran Etexilate Market, 2021-2025 US$ 2,600.00

Dabigatran Etexilate is an oral anticoagulant drug used for the prevention of thrombus and embolus formation after major orthopedic surgery (hip or knee replacement) and for the prevention of stroke i...

September 2021 40 pages
Research Report on China's Escitalopram Market, 2021-2025 US$ 2,600.00

Depression is the fourth leading disease in the world and is expected to become the first by 2030. However, the medical prevention and treatment of depression in China is still of low recognition rate...

September 2021 40 pages
Research Report on China's Exemestane Market, 2021-2025 US$ 2,600.00

Breast cancer is a common malignant tumor in menopausal women, and now ranks first among malignant tumors in women. Recently, the number of breast cancer patients in China has been increasing year by...

September 2021 40 pages
Research Report on China's Gefitinib Market, 2021-2025 US$ 2,600.00

Lung cancer is the most common type of cancer and the leading cause of cancer deaths. 19.29 million new cancer cases were diagnosed worldwide in 2020, 4.57 million of which were in China, accounting f...

September 2021 40 pages
Research Report on China's Levetiracetam Market, 2021-2025 US$ 2,600.00

Epilepsy is second only to stroke as a common chronic neurological disorder characterized by excessive neuronal discharge in the brain resulting in recurrent, seizure and transient central nervous sys...

September 2021 40 pages
Research Report on China's LNG (liquefied natural gas) Import, 2021-2025 US$ 3,000.00

In 2020, China's natural gas production reached 192.5 billion cubic meters, a year-on-year increase of 9.8%, of which coal-to-gas production was 4 billion cubic meters; coal-bed methane production 6.5...

September 2021 70 pages
Research Report on China's Lobaplatin Market, 2021-2025 US$ 2,600.00

According to IARC of WHO, globally, there were 19.29 million new cases of cancer in 2020, among which 2.26 million were cases of breast cancer, surpassing the 2.2 million cases of lung cancer. Breast...

September 2021 40 pages
Research Report on China's Mesalazine Market, 2021-2025 US$ 2,600.00

Inflammatory bowel disease (IBD) is a chronic disease of the digestive system with unclear etiology, difficulty to cure, and recurrent attacks with multiple complications. The incidence of IBD in Chin...

September 2021 40 pages
Research Report on China's Nicorandil Market, 2021-2025 US$ 2,600.00

In China, the crude incidence rate of hypertension among residents over the age of 18 is close to 30%, and the most common hazard of hypertension is coronary heart disease. By the end of 2020, it is e...

September 2021 40 pages
Research Report on China's Roxatidine Market, 2021-2025 US$ 2,600.00

Peptic ulcers and gastrointestinal bleeding are common diseases in China with a large number of patients. Due to the fast pace of modern life, accelerated urbanization and great mental stress, the num...

September 2021 40 pages
Research Report on China's Sorafenib Market, 2021-2025 US$ 2,600.00

Hepatocellular carcinoma (HCC) is the most common type of chronic liver cancer in adults and the most common cause of death in patients with cirrhosis. Hepatocellular carcinoma (HCC) is the third most...

September 2021 40 pages
Research Report on China's Venlafaxine Market, 2021-2025 US$ 2,600.00

Depression is the result of a complex interplay of social, psychological and physical factors. People who experience adverse events in their lives are more likely to develop depression. Depression can...

September 2021 40 pages
Research Report on China's Zoledronic Acid Market, 2021-2025 US$ 2,600.00

Osteoporosis is a metabolic disease caused by a combination of endocrine, nutritional, immune, and genetic factors, and is characterized by increasing bone fragility and fracture due to a gradual decr...

September 2021 40 pages
Investigation Report on China's Atorvastatin Market 2021-2025 US$ 2,600.00

Atorvastatin is a statin drug, which is used to lower blood cholesterol levels. This common drug is mainly used to treat high cholesterol, hyperlipidemia, and coronary heart disease. The original drug...

July 2021 50 pages
Investigation Report on China's Capecitabine Market 2021-2025 US$ 2,600.00

Capecitabine is a pyrimidine analog (pentoxycarbonyl-deoxy-cytosine nucleoside) that has anti-tumor activity to inhibit a variety of solid tumors, including breast and colon cancer. Capecitabine was d...

July 2021 50 pages
Investigation Report on China's Caspofungin Market 2021-2025 US$ 2,600.00

Caspofungin is the first echinocandin antifungal drug. It has a broad antibacterial spectrum, a long half-life, a high binding rate to human serum proteins, and a few adverse reactions. It is known as...

July 2021 50 pages
Investigation Report on China's Hemocoagulase Market 2021-2025 US$ 2,600.00

Hemocoagulase, developed by Swiss Sugo Pharmaceuticals, is a high-purity, single-component hemagglutinin clinical hemostatic drug. Its original drug is called REPTILASE, which is not on the market in...

July 2021 50 pages
Investigation Report on China's Iohexol Market 2021-2025 US$ 2,600.00

Iohexol is a non-ionic X-ray contrast agent. Iohexol injection is suitable for intravascular and intracavitary injections in adults and children. In clinical angiography (cerebrovascular angiography,...

July 2021 50 pages
Investigation Report on China's Linezolid Market 2021-2025 US$ 2,600.00

Linezolid is an oxazolidinone antibiotic, mainly used to treat infections caused by gram-positive (G+) cocci, including suspected or confirmed hospital-acquired pneumonia (HAP) caused by methicillin-r...

July 2021 50 pages
Investigation Report on China's Metformin Market 2021-2025 US$ 2,600.00

Metformin is the first-line drug for the treatment of type 2 diabetes, especially in people who are overweight. Metformin was originally developed by Merck Sharp & Dohme (trade name: GLUCOPHAGE ). GLU...

July 2021 50 pages
Investigation Report on China's Mycophenolate Mofetil Market 2021-2025 US$ 2,600.00

Mycophenolate mofetil is a powerful inhibitor of lymphocyte proliferation and has been used to prevent acute rejection of allografts since the early 1990s. Mycophenolate mofetil is also widely used as...

July 2021 50 pages
Investigation Report on China's Nicergoline Market 2021-2025 US$ 2,600.00

Nicergoline is a kind of ergot derivative, used to treat Alzheimer's disease and other vascular diseases, originally researched by Pfizer Pharmaceuticals. Since its successful development in the 1960s...

July 2021 50 pages
Investigation Report on China's Nifedipine Market 2021-2025 US$ 2,600.00

Nifedipine is a dihydropyridine calcium channel blocker, which is mainly used to bind to L-type calcium channels. Nifedipine is mainly used to treat chronic stable angina pectoris, vasospasm angina pe...

July 2021 50 pages
Investigation Report on China's Octreotide Market 2021-2025 US$ 2,600.00

Octreotide is a derivative of artificially modified natural somatostatin, which is an octapeptide. Its physiological effects include inhibiting growth hormone function, inhibiting the secretion of gas...

July 2021 50 pages
Investigation Report on China's Pregabalin Market 2021-2025 US$ 2,600.00

Pregabalin is an ion channel modulator used to treat epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder. Its product, LYRICA was originally developed by Pfizer Ltd. LYRICA was...

July 2021 50 pages
Investigation Report on China's Temozolomide Market 2021-2025 US$ 2,600.00

Temozolomide is a second-generation alkylating agent. It is an oral chemotherapeutic drug used to treat brain cancers such as adult malignant glioma and malignant melanoma. It was developed by Merck &...

July 2021 50 pages
Investigation Report on China's Tigecycline Market 2021-2025 US$ 2,600.00

Tigecycline is a broad-spectrum glycyl cyclic peptide antibiotic administered intravenously. Tigecycline is approved for complicated skin and skin structure infections or complicated intra-abdominal i...

July 2021 50 pages
Research Report on China's Mecobalamin Market, 2021-2025 US$ 2,600.00

Mecobalamin is an endogenous coenzyme B12, which has a good effect on neuronal conduction compared with other types of vitamin B12, and can promote nucleic acid-protein-lipid metabolism through methyl...

July 2021 50 pages
Investigation Report on China's Recombinant human thrombopoietin (rhTPO) Market 2021-2025 US$ 2,600.00

... with thrombopenia increases in China, the demand for Recombinant Human Thrombopoietin will also increase. Considering the high growth rate of the Recombinant Human Thrombopoietin market, Recombinant Human Thrombopoietin products by other ...

June 2021 50 pages
Investigation Report on China's Acetylcysteine Market 2021-2025 US$ 2,600.00

Acetylcysteine, also known as N-acetylcysteine (NAC), is a medication that is used to treat paracetamol (acetaminophen) overdose, and to loosen thick mucus in individuals with chronic bronchopulmonary...

June 2021 50 pages
Investigation Report on China's Anlotinib Market 2021-2025 US$ 2,600.00

Anlotinib is an oral multi-targeting small-molecule tyrosine kinase inhibitor that can target multiple angiogenic factor receptors to inhibit tumor angiogenesis. It can be used for advanced non-small...

June 2021 50 pages
Investigation Report on China's Dexmedetomidine Market 2021-2025 US$ 2,600.00

Dexmedetomidine is a highly selective ?2-adrenergic receptor agonist. It is mainly used clinically for the sedation of tracheal intubation and mechanical ventilation in surgical patients undergoing ge...

June 2021 50 pages
Investigation Report on China's Doxorubicin Market 2021-2025 US$ 2,600.00

Doxorubicin belongs to the anthracycline class (Anthracycline) antibiotics, which can inhibit the synthesis of RNA and DNA. It has a strong inhibitory effect on RNA and has a broad anti-tumor spectrum...

June 2021 50 pages
Investigation Report on China's Emtricitabine/Tenofovir Market 2021-2025 US$ 2,600.00

Emtricitabine/Tenofovir is the first HIV drug approved for prophylaxis. It was developed by Gilead Sciences Inc (the original drug is called TRUVADA). Its product was first approved in the United Stat...

June 2021 50 pages
Investigation Report on China's Enteral Nutrition Market 2021-2025 US$ 2,600.00

Enteral nutrition is mainly used for preoperative feeding of patients with anorexia and related diseases, including mechanical gastrointestinal dysfunction, critical illness and malnutrition. It was d...

June 2021 50 pages
Investigation Report on China's Express Delivery Industry 2021-2025 US$ 2,600.00

Express delivery is a door-to-door logistics activity with postal functions, which means express companies use rail, road, and air transportation to quickly deliver customers' goods. According to CRI’...

June 2021 50 pages
Investigation Report on China's Goserelin Market 2021-2025 US$ 2,600.00

Goserelin is a synthetic analogue of a naturally occurring gonadotropin-releasing hormone (GnRH). Goserelin is developed by AstraZeneca, is mainly used to treat advanced breast and prostate cancer. In...

June 2021 50 pages
Investigation Report on China's Hydrotalcite Market, 2021-2025 US$ 2,600.00

Hydrotalcite is suitable for acute and chronic gastritis, reflux esophagitis, gastric and duodenal ulcers, stomach pain, heartburn, acid belching, fullness and other uncomfortable symptoms related to...

June 2021 50 pages
Investigation Report on China's Insulin Glargine Market 2021-2025 US$ 2,600.00

Insulin Glargine is a long-acting human insulin analog that can control the patient's blood sugar more effectively and steadily. It is often used to treat type 1 and type 2 diabetes. Its original rese...

June 2021 50 pages
Investigation Report on China's Leuprorelin Market 2021-2025 US$ 2,600.00

Leuprolide is a synthetic gonadotropin drug used to treat hormone-responsive cancers such as prostate cancer and breast cancer. It can also be used to treat precocious puberty and prevent premature ov...

June 2021 50 pages
Investigation Report on China's Levofloxacin Market 2021-2025 US$ 2,600.00

Levofloxacin, developed by Daiichi Sankyo, is used to treat bacterial infectious diseases such as community pneumonia, sinusitis, urinary tract infections. Levofloxacin tablets were approved in China...

June 2021 50 pages
Investigation Report on China's Moxifloxacin Market 2021-2025 US$ 2,600.00

Moxifloxacin is a fourth-generation synthetic quinolone antibacterial drug (8-methoxy-fluoroquinolone antibiotic) developed by Bayer Vital GmbH. It was approved for marketing by the FDA in December 19...

June 2021 50 pages
Investigation Report on Global and China's MOSFET Market 2021-2025 US$ 2,600.00

MOSFET is an acronym for Metal Oxide Semiconductor Field Effect Transistor, also known as MOS, MOS transistor. The name 'metal–oxide–semiconductor' (MOS) typically refers to a type of insulated-gate f...

June 2021 50 pages
Investigation Report on China's Daratumumab Market 2021-2025 US$ 2,600.00

Daratumumab, developed by Johnson & Johnson, is a monoclonal antibody available for the treatment of myeloma. Its product DARZALEX was approved for the treatment of patients with multiple myeloma who...

June 2021 50 pages
Investigation Report on China's Docetaxel Market 2021-2025 US$ 2,600.00

Docetaxel, sold under the brand name Taxotere, is a paclitaxel anti-tumor drug used for the treatment of locally advanced or metastatic non-small cell lung cancer. Docetaxel injection was first develo...

June 2021 50 pages
Investigation Report on China's Liraglutide Market 2021-2025 US$ 2,600.00

Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, developed by Novo Nordisk A/S. Its product VICTOZA firstly launched in the EU in July 2009 and firstly approved to enter the Chinese...

June 2021 50 pages
Investigation Report on China's Omalizumab Market 2021-2025 US$ 2,600.00

Omalizumab, developed by Novartis Europharm, is the only approved antibody designed to target and block immunoglobulin E (IgE). At the end of 2017, the FDA approved the registration of Novartis Europh...

June 2021 50 pages
Investigation Report on China's Oxaliplatin Market 2021-2025 US$ 2,600.00

Oxaliplatin (OXA) is the third-generation platinum anti-tumor drug after cisplatin and carboplatin. Oxaliplatin was jointly developed by Sanofi and Debiopharm for the first-line treatment of metastati...

June 2021 50 pages

Filters

Search

Categories

1
1
1
3
3
1
3
1
1
2
1
1
1
3
1
1
1
1
1
7
2
1
1
1
2
1
1
5
2
1
6
1
1
1
1
4
4
1
1
4
2
3
3
2
1
1
8
4
2
3
2
5
2
1
1
1
1
14
10
2
1
1
1
1
1
1
1
1
47
6
3
1
1
1
1
3
3
1
1
1
4
4
2
1
1
5
9
6
2
4
1
12
9
7
7
7
6
6
4
4
3
2
2
2
2
1
1
289
17
10
10
9
7
6
6
3
3
2
2
1
1
7
4
2
1
9
4
3
3
1
7
19
3
2
7
3
2
2
1
1
67
62
44
14
12
9
6
6
5
3
3
3
2
2
2
1

Publishers

1,023

Regions

5
1
15
3
1
1
1
996

Price

Date

Pages

Offers